DNAprint Genomics (DNAG)

[dgplexus]

Frogdreaming,

If you wish to dissuade people from buying DNAG stock based on these speculations of yours, surrounding the "Orchid option," you should spell out succinctly just how this "Orchid option" negatively impacts DNAPrint Genomics, its ability to form deals and conduct business, etc. Leaving it as a vague scare is not responsible or informative. Anyway, obviously deals HAVE been forged... DNA Direct, Beckman Coulter (if they hold the option, is that supposed to stop *them* from dealing with DNAPrint?,) BioServe, etc. It doesn't sound like a freeze to me. Do I smell scaremongering?